de Bree R - Search Results

1

Head and Neck Cancer: A Review of the Impact of Treatment Delay on Outcome.

Coca-Pelaz A, Takes RP, Hutcheson K, Saba NF, Haigentz M Jr, Bradford CR, de Bree R, Strojan P, Lund VJ, Mendenhall WM, Nixon IJ, Quer M, Rinaldo A, Ferlito A. Coca-Pelaz A, et al. Among authors: de bree r. Adv Ther. 2018 Feb;35(2):153-160. doi: 10.1007/s12325-018-0663-7. Epub 2018 Feb 2. Adv Ther. 2018. PMID: 29396681 Review.

2

Perspectives of monoclonal antibodies for detection and treatment of head and neck tumours.

Quak J, Gerretsen M, De Bree R, Brakenhof R, Van Dongen G, Snow G. Quak J, et al. Among authors: de bree r. Anticancer Res. 1993 Nov-Dec;13(6B):2533-9. Anticancer Res. 1993. PMID: 8135493

3

Clinical imaging of head and neck cancer with technetium-99m-labeled monoclonal antibody E48 IgG or F(ab')2.

de Bree R, Roos JC, Quak JJ, den Hollander W, van den Brekel MW, van der Wal JE, Tobi H, Snow GB, van Dongen GA. de Bree R, et al. J Nucl Med. 1994 May;35(5):775-83. J Nucl Med. 1994. PMID: 8176458 Free article.

4

Squamous cell carcinoma-associated antigens used in novel strategies for the detection and treatment of minimal residual head and neck cancer.

van Dongen GA, Brakenhoff RM, ten Brink CT, van Gog FB, de Bree R, Quak JJ, Snow GB. van Dongen GA, et al. Among authors: de bree r. Anticancer Res. 1996 Jul-Aug;16(4C):2409-13. Anticancer Res. 1996. PMID: 8816843 Review.

5

Selection of monoclonal antibody E48 IgG or U36 IgG for adjuvant radioimmunotherapy in head and neck cancer patients.

de Bree R, Roos JC, Plaizier MA, Quak JJ, van Kamp GJ, den Hollander W, Snow GB, van Dongen GA. de Bree R, et al. Br J Cancer. 1997;75(7):1049-60. doi: 10.1038/bjc.1997.179. Br J Cancer. 1997. PMID: 9083342 Free PMC article.

6

The impact of tumour volume and other characteristics on uptake of radiolabelled monoclonal antibodies in tumour tissue of head and neck cancer patients.

de Bree R, Kuik DJ, Quak JJ, Roos JC, van den Brekel MW, Castelijns JA, van Wagtendonk FW, Greuter H, Snow GB, van Dongen GA. de Bree R, et al. Eur J Nucl Med. 1998 Nov;25(11):1562-5. doi: 10.1007/s002590050336. Eur J Nucl Med. 1998. PMID: 9799354 Clinical Trial.

7

Radioimmunoscintigraphy and biodistribution of technetium-99m-labeled monoclonal antibody U36 in patients with head and neck cancer.

de Bree R, Roos JC, Quak JJ, den Hollander W, Snow GB, van Dongen GA. de Bree R, et al. Clin Cancer Res. 1995 Jun;1(6):591-8. Clin Cancer Res. 1995. PMID: 9816020

8

Sensitive detection of squamous cells in bone marrow and blood of head and neck cancer patients by E48 reverse transcriptase-polymerase chain reaction.

Brakenhoff RH, Stroomer JG, ten Brink C, de Bree R, Weima SM, Snow GB, van Dongen GA. Brakenhoff RH, et al. Among authors: de bree r. Clin Cancer Res. 1999 Apr;5(4):725-32. Clin Cancer Res. 1999. PMID: 10213205

9

Screening for distant metastases in patients with head and neck cancer.

de Bree R, Deurloo EE, Snow GB, Leemans CR. de Bree R, et al. Laryngoscope. 2000 Mar;110(3 Pt 1):397-401. doi: 10.1097/00005537-200003000-00012. Laryngoscope. 2000. PMID: 10718426

10

Radioimmunotherapy in patients with head and neck squamous cell carcinoma: initial experience.

Colnot DR, Quak JJ, Roos JC, de Bree R, Wilhelm AJ, Snow GB, van Dongen GA. Colnot DR, et al. Among authors: de bree r. Head Neck. 2001 Jul;23(7):559-65. doi: 10.1002/hed.1078. Head Neck. 2001. PMID: 11400244

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

504 results

Search Page

Filters